Anbalagan Saravanan

Anbalagan Saravanan

Auto-generated profile, based on publicly available information

Anbalagan Saravanan

Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Chemosphere
Verified
Journal Article
Closed access
ASA. Saravanan
A. Saravanan
VDV.C. Deivayanai
V.C. Deivayanai
PKP. Senthil Kumar
P. Senthil Kumar
GRGayathri Rangasamy
Gayathri Rangasamy
RHR.V. Hemavathy
R.V. Hemavathy
KAKrishnapandi Alagumalai
Krishnapandi Alagumalai

1 February 2019 in Environmental Technology & Innovation
Verified
Journal Article
Closed access
SJS. Jeevanantham
S. Jeevanantham
ASA. Saravanan
A. Saravanan
RHR.V. Hemavathy
R.V. Hemavathy
PKP. Senthil Kumar
P. Senthil Kumar
PYP.R. Yaashikaa
P.R. Yaashikaa
DYD. Yuvaraj
D. Yuvaraj

1 April 2020 in Journal of Environmental Chemical Engineering
Verified
Journal Article
Closed access
ASA. Saravanan
A. Saravanan
SJS Jeevanantham
S Jeevanantham
VNV. Anantha Narayanan
V. Anantha Narayanan
PKP. Senthil Kumar
P. Senthil Kumar
PYP.R Yaashikaa
P.R Yaashikaa
CMC.M Mathan Muthu
C.M Mathan Muthu

7 June 2023 in Journal of Cleaner Production
Verified
Journal Article
Closed access
ASA. Saravanan
A. Saravanan
PYP.R. Yaashikaa
P.R. Yaashikaa
PKP. Senthil Kumar
P. Senthil Kumar
AVA.S. Vickram
A.S. Vickram
SKS. Karishma
S. Karishma
GRGayathri Rangasamy
Gayathri Rangasamy

9 December 2024 in Cancer Pathogenesis and Therapy
Verified
Journal Article
Open access
VDV.C. Deivayanai
V.C. Deivayanai
PTP. Thamarai
P. Thamarai
SKS. Karishma
S. Karishma
ASA. Saravanan
A. Saravanan
PYP.R. Yaashikaa
P.R. Yaashikaa
SSS. Shruthi
S. Shruthi
One in six deaths worldwide is caused by cancer, making it a major global health concern. Despite their effectiveness, traditional treatment approaches such as radiation therapy, chemotherapy, and surgery frequently have negative side effects and high costs. New approaches, such as gene therapy, are promising but are hampered by high costs and accessibility problems. Nanoparticles (NPs) facilitate targeted drug delivery by leveraging passive targeting mechanisms, such as the enhanced permeability and retention (EPR) effect, and by actively targeting surfaces with ligands for site-specific binding through the functionalization of surfaces. This approach enhances therapeutic results while lowering off-target toxicities. Notably, chemotherapeutic medications, immunotherapeutic agents, and photothermal therapies can now be delivered more precisely to the affected site using NP-based systems. By boosting particularity, reducing side effects, and tackling drug resistance, nanomedicine has the potential to revolutionize cancer treatment and ultimately advance personalized oncological care. These advancements highlight the possibilities for field growth, and future development regulations are detailed.

25 March 2024 in Chemosphere
Verified
Journal Article
Closed access
PYP.R. Yaashikaa
P.R. Yaashikaa
SKS. Karishma
S. Karishma
RKR. Kamalesh
R. Kamalesh
SASaravanan A
Saravanan A
AVA.S. Vickram
A.S. Vickram
KAK. Anbarasu
K. Anbarasu